From Wikipedia, the free encyclopedia
SRT-2104
Identifiers
  • 4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard ( EPA)
Chemical and physical data
FormulaC26H24N6O2S2
Molar mass516.64 g·mol−1
3D model ( JSmol)
  • CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6
  • InChI=1S/C26H24N6O2S2/c1-17-23(36-25(28-17)18-5-4-8-27-13-18)24(33)29-21-7-3-2-6-20(21)22-15-32-19(16-35-26(32)30-22)14-31-9-11-34-12-10-31/h2-8,13,15-16H,9-12,14H2,1H3,(H,29,33)
  • Key:LAMQVIQMVKWXOC-UHFFFAOYSA-N

SRT-2104 is an experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1. The compound progressed to Phase II human trials for Type II diabetes before development was discontinued, however it continues to be widely used in animal research into the functions of SIRT1. [1] [2] [3] [4] [5]

See also

References

  1. ^ Baksi A, Kraydashenko O, Zalevkaya A, Stets R, Elliott P, Haddad J, et al. (July 2014). "A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes". British Journal of Clinical Pharmacology. 78 (1): 69–77. doi: 10.1111/bcp.12327. PMC  4168381. PMID  24446723.
  2. ^ Bonkowski MS, Sinclair DA (November 2016). "+ and sirtuin-activating compounds". Nature Reviews. Molecular Cell Biology. 17 (11): 679–690. doi: 10.1038/nrm.2016.93. PMC  5107309. PMID  27552971.
  3. ^ Miyaji N, Nishida K, Tanaka T, Araki D, Kanzaki N, Hoshino Y, et al. (January 2020). "Inhibition of Knee Osteoarthritis Progression in Mice by Administering SRT2014, an Activator of Silent Information Regulator 2 Ortholog 1". Cartilage. 13 (2_suppl): 1356S–1366S. doi: 10.1177/1947603519900795. PMC  8804762. PMID  31989845.
  4. ^ Gu C, Zhang Q, Ni D, Xiao QF, Cao LF, Fei CY, et al. (August 2020). "Therapeutic Effects of SRT2104 on Lung Injury in Rats with Emphysema via Reduction of Type II Alveolar Epithelial Cell Senescence". Copd. 17 (4): 444–451. doi: 10.1080/15412555.2020.1797657. PMID  32722945. S2CID  220852823.
  5. ^ Lei Y, Wang J, Wang D, Li C, Liu B, Fang X, et al. (May 2020). "SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex". Molecular Psychiatry. 25 (5): 1094–1111. doi: 10.1038/s41380-019-0352-1. PMC  7192847. PMID  30705425.
From Wikipedia, the free encyclopedia
SRT-2104
Identifiers
  • 4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard ( EPA)
Chemical and physical data
FormulaC26H24N6O2S2
Molar mass516.64 g·mol−1
3D model ( JSmol)
  • CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6
  • InChI=1S/C26H24N6O2S2/c1-17-23(36-25(28-17)18-5-4-8-27-13-18)24(33)29-21-7-3-2-6-20(21)22-15-32-19(16-35-26(32)30-22)14-31-9-11-34-12-10-31/h2-8,13,15-16H,9-12,14H2,1H3,(H,29,33)
  • Key:LAMQVIQMVKWXOC-UHFFFAOYSA-N

SRT-2104 is an experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1. The compound progressed to Phase II human trials for Type II diabetes before development was discontinued, however it continues to be widely used in animal research into the functions of SIRT1. [1] [2] [3] [4] [5]

See also

References

  1. ^ Baksi A, Kraydashenko O, Zalevkaya A, Stets R, Elliott P, Haddad J, et al. (July 2014). "A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes". British Journal of Clinical Pharmacology. 78 (1): 69–77. doi: 10.1111/bcp.12327. PMC  4168381. PMID  24446723.
  2. ^ Bonkowski MS, Sinclair DA (November 2016). "+ and sirtuin-activating compounds". Nature Reviews. Molecular Cell Biology. 17 (11): 679–690. doi: 10.1038/nrm.2016.93. PMC  5107309. PMID  27552971.
  3. ^ Miyaji N, Nishida K, Tanaka T, Araki D, Kanzaki N, Hoshino Y, et al. (January 2020). "Inhibition of Knee Osteoarthritis Progression in Mice by Administering SRT2014, an Activator of Silent Information Regulator 2 Ortholog 1". Cartilage. 13 (2_suppl): 1356S–1366S. doi: 10.1177/1947603519900795. PMC  8804762. PMID  31989845.
  4. ^ Gu C, Zhang Q, Ni D, Xiao QF, Cao LF, Fei CY, et al. (August 2020). "Therapeutic Effects of SRT2104 on Lung Injury in Rats with Emphysema via Reduction of Type II Alveolar Epithelial Cell Senescence". Copd. 17 (4): 444–451. doi: 10.1080/15412555.2020.1797657. PMID  32722945. S2CID  220852823.
  5. ^ Lei Y, Wang J, Wang D, Li C, Liu B, Fang X, et al. (May 2020). "SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex". Molecular Psychiatry. 25 (5): 1094–1111. doi: 10.1038/s41380-019-0352-1. PMC  7192847. PMID  30705425.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook